- 全部删除
- 您的购物车当前为空
TFAP4/Wnt/β-catenin-IN-1 (Compound A61) 是一种可口服的TFAP4/Wnt/β-catenin抑制剂,表现出显著的抗癌作用,能抑制多种癌细胞,如胃癌、肺癌和乳腺癌等,对 MGC-803 胃癌细胞的抗癌活性最为显著 (IC50: 3.92 μM)。它通过抑制 TFAP4/Wnt/β-catenin 信号通路,诱导癌细胞凋亡 (apoptosis) 和细胞周期阻滞 (S期)。TFAP4/Wnt/β-catenin-IN-1 可用于胃癌研究。
TFAP4/Wnt/β-catenin-IN-1 (Compound A61) 是一种可口服的TFAP4/Wnt/β-catenin抑制剂,表现出显著的抗癌作用,能抑制多种癌细胞,如胃癌、肺癌和乳腺癌等,对 MGC-803 胃癌细胞的抗癌活性最为显著 (IC50: 3.92 μM)。它通过抑制 TFAP4/Wnt/β-catenin 信号通路,诱导癌细胞凋亡 (apoptosis) 和细胞周期阻滞 (S期)。TFAP4/Wnt/β-catenin-IN-1 可用于胃癌研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
产品描述 | TFAP4/Wnt/β-catenin-IN-1 (Compound A61) is an orally active inhibitor targeting the TFAP4/Wnt/β-catenin pathway. Known for its potent anticancer properties, it effectively targets various cancer cells, including those of gastric, lung, and breast cancer, with the strongest activity observed in MGC-803 gastric cancer cells (IC50: 3.92 μM). By inhibiting the TFAP4/Wnt/β-catenin signaling pathway, it induces apoptosis and S phase cell cycle arrest. TFAP4/Wnt/β-catenin-IN-1 is applicable for gastric cancer research. |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容